Survival of patients receiving a liver transplant for hepatocellular carcinoma, and risk of tumor recurrence.

Objective: The goal of this research has been to evaluate the survival, in long and short term, of the patient receiving liver transplant for hepatocellular carcinoma (HCC), the risk of post-transplant tumor relapse and factors related to this complication.

Design: Retrospective study of a consecutive series of patients having had liver transplant for HCC.

Patients And Methodology: Transplant patients for HCC from 1989 to November 2003.

Adjuvant chemotherapy for prevention of recurrence of invasive hepatocellular carcinoma after orthotopic liver transplantation.

Unlabelled: Orthotopic liver transplantation (OLT) is the best treatment for nonresectable hepatocellular carcinoma (HCC), but tumor recurrence reduces long-term and medium-term survival. The effectiveness of adjuvant chemotherapy to prevent tumor recurrence has not been fully established.

Methods: Three hundred eighty-seven consecutive patients, including 43 with HCC superimposed on liver cirrhosis, underwent OLT.

Biliopancreatic tumors: patient survival and quality of life after palliative treatment.

Objectives: to analyse survival and quality of life of patients with malignant obstructive jaundice after palliative treatment, comparing endoscopic stent insertion and palliative surgical (palliative resection and bypass surgical).

Patients And Method: eighty and seven patients were included in a trial. They were distributed to endoscopic stent (50) and palliative surgical (37).